Business
Faron Pharmaceuticals Ltd: Holding(s) in Comp...
Acme Investments SPF Sarl, fully owned by Timo Syrjälä, has notified Faron Pharmaceuticals Ltd of a change in its major holding due to a private placement. As of December 3, 2025, Acme Investments SPF Sarl holds 14.96% of the voting rights, representing 17,120,400 voting rights, a decrease from its previous holding of 15.18% or 17,225,396 voting rights. This change occurred following a share issue that increased the total number of registered company shares to 114,420,465. Disclaimer*
About this update from Faron Pharmaceuticals Oy
[{"type":"text","content":"\n\n \n Faron Pharmaceuticals Ltd | Company announcement | December 04, 2025 at 18:00:00 EET\nTR-1: Standard form for notification of major holdingsNOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:Faron Pharmaceuticals Ltd1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)Non-UK issuerX2. Reason for the notification (please mark the appropriate box or boxes with an “X”)An acquisition or disposal of voting rightsAn acquisition or disposal of financial instrumentsAn event changing the breakdown of voting rightsOther (please specify) iii: Change due the Private Placementx3. Details of person subject to the notification obligation ivNameTimo SyrjäläCity and country of registered office (if applicable)Monaco4. Full name of shareholder(s) (if different from 3.) vNameAcme Investments SPF SarlCity and country of registered office (if applicable)Luxembourg5. Date on which the threshold was crossed or reached vi:03.12.20256. Date on which issuer notified (DD/MM/YYYY):04.12.20257. Total positions of person(s) subject to the notification obligation% of voting rights attached to shares (total of 8. A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights held in issuer (8.A + 8.B) viiResulting situation on the date on which threshold was crossed or reached14,9617.120.400Position of previous notification (ifapplicable)15,1817.225.3968. Notified details of the resulting situation on the date on which the threshold was crossed or reached viiiA: Voting rights attached to sharesClass/type ofsharesISIN code (if possible)Number of voting rights ix% of voting rightsDirect(DTR5.1)Indirect(DTR5.2.1)Direct(DTR5.1)Indirect(DTR5.2.1)FI40001533095.185.52811.934.8724,53%10,43%SUBTOTAL 8. A17.120.40014,96%B 1: Financial Instruments according to DTR5.3.1R (1) (a)Type of financial instrumentExpirationdate xExercise/ Conversion Period xiNumber of voting rights that may be acquired if the instrument isexercised/converted.% of voting rightsSUBTOTAL 8. B 1B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)Type of financial instrument...